190 related articles for article (PubMed ID: 15602826)
1. Polymorphism of N-acetyltransferase 2 (NAT2) gene polymorphism in shanghai population: occupational and non-occupational bladder cancer patient groups.
Ma QW; Lin GF; Chen JG; Xiang CQ; Guo WC; Golka K; Shen JH
Biomed Environ Sci; 2004 Sep; 17(3):291-8. PubMed ID: 15602826
[TBL] [Abstract][Full Text] [Related]
2. The enhanced bladder cancer susceptibility of NAT2 slow acetylators towards aromatic amines: a review considering ethnic differences.
Golka K; Prior V; Blaszkewicz M; Bolt HM
Toxicol Lett; 2002 Mar; 128(1-3):229-41. PubMed ID: 11869833
[TBL] [Abstract][Full Text] [Related]
3. N-Acetyltransferase 2 gene polymorphism in a group of senile dementia patients in Shanghai suburb.
Guo WC; Lin GF; Zha YL; Lou KJ; Ma QW; Shen JH
Acta Pharmacol Sin; 2004 Sep; 25(9):1112-7. PubMed ID: 15339384
[TBL] [Abstract][Full Text] [Related]
4. NAT2 slow acetylation and bladder cancer in workers exposed to benzidine.
Carreón T; Ruder AM; Schulte PA; Hayes RB; Rothman N; Waters M; Grant DJ; Boissy R; Bell DA; Kadlubar FF; Hemstreet GP; Yin S; LeMasters GK
Int J Cancer; 2006 Jan; 118(1):161-8. PubMed ID: 16003747
[TBL] [Abstract][Full Text] [Related]
5. Occupational history and genetic N-acetyltransferase polymorphism in urothelial cancer patients of Leverkusen, Germany.
Golka K; Prior V; Blaszkewicz M; Cascorbi I; Schöps W; Kierfeld G; Roots I; Bolt HM
Scand J Work Environ Health; 1996 Oct; 22(5):332-8. PubMed ID: 8923605
[TBL] [Abstract][Full Text] [Related]
6. Refinement of the prediction of N-acetyltransferase 2 (NAT2) phenotypes with respect to enzyme activity and urinary bladder cancer risk.
Selinski S; Blaszkewicz M; Ickstadt K; Hengstler JG; Golka K
Arch Toxicol; 2013 Dec; 87(12):2129-39. PubMed ID: 24221535
[TBL] [Abstract][Full Text] [Related]
7. Human arylamine N-acetyltransferase 2 polymorphism and susceptibility to allergic contact dermatitis.
Nacak M; Erbagci Z; Aynacioglu AS
Int J Dermatol; 2006 Mar; 45(3):323-6. PubMed ID: 16533241
[TBL] [Abstract][Full Text] [Related]
8. The impact of interindividual variation in NAT2 activity on benzidine urinary metabolites and urothelial DNA adducts in exposed workers.
Rothman N; Bhatnagar VK; Hayes RB; Zenser TV; Kashyap SK; Butler MA; Bell DA; Lakshmi V; Jaeger M; Kashyap R; Hirvonen A; Schulte PA; Dosemeci M; Hsu F; Parikh DJ; Davis BB; Talaska G
Proc Natl Acad Sci U S A; 1996 May; 93(10):5084-9. PubMed ID: 8643532
[TBL] [Abstract][Full Text] [Related]
9. Differential association for N-acetyltransferase 2 genotype and phenotype with bladder cancer risk in Chinese population.
Quan L; Chattopadhyay K; Nelson HH; Chan KK; Xiang YB; Zhang W; Wang R; Gao YT; Yuan JM
Oncotarget; 2016 Jun; 7(26):40012-40024. PubMed ID: 27223070
[TBL] [Abstract][Full Text] [Related]
10. Effects of N-acetyl transferase 1 and 2 polymorphisms on bladder cancer risk in Caucasians.
Gu J; Liang D; Wang Y; Lu C; Wu X
Mutat Res; 2005 Mar; 581(1-2):97-104. PubMed ID: 15725609
[TBL] [Abstract][Full Text] [Related]
11. N-acetyltransferase polymorphism in patients with Behçet's disease.
Aynacioglu AS; Bozkurt A; Nacak M; Kortunay S; Tunc R; Dincel A; Kayaalp SO
Eur J Clin Pharmacol; 2001 Nov; 57(9):659-62. PubMed ID: 11791896
[TBL] [Abstract][Full Text] [Related]
12. N-acetyltransferase 2 phenotype, occupation, and bladder cancer risk: results from the EPIC cohort.
Pesch B; Gawrych K; Rabstein S; Weiss T; Casjens S; Rihs HP; Ding H; Angerer J; Illig T; Klopp N; Bueno-de-Mesquita B; Ros MM; Kaaks R; Chang-Claude J; Roswall N; Tjønneland A; Overvad K; Clavel-Chapelon F; Boutron-Ruault MC; Dossus L; Boeing H; Weikert S; Trichopoulos D; Palli D; Sieri S; Tumino R; Panico S; Quirós JR; González C; Sánchez MJ; Dorronsoro M; Navarro C; Barricarte A; Ljungberg B; Johansson M; Ulmert D; Ehrnström R; Khaw KT; Wareham N; Key TJ; Ferrari P; Romieu I; Riboli E; Brüning T; Vineis P
Cancer Epidemiol Biomarkers Prev; 2013 Nov; 22(11):2055-65. PubMed ID: 24092628
[TBL] [Abstract][Full Text] [Related]
13. Association of NAT1 and NAT2 polymorphisms to urinary bladder cancer: significantly reduced risk in subjects with NAT1*10.
Cascorbi I; Roots I; Brockmöller J
Cancer Res; 2001 Jul; 61(13):5051-6. PubMed ID: 11431340
[TBL] [Abstract][Full Text] [Related]
14. NAT2 gene polymorphism as a possible marker for susceptibility to bladder cancer in Japanese.
Inatomi H; Katoh T; Kawamoto T; Matsumoto T
Int J Urol; 1999 Sep; 6(9):446-54. PubMed ID: 10510890
[TBL] [Abstract][Full Text] [Related]
15. Effect of NAT2 gene polymorphism on bladder cancer risk in Slovak population.
Klimčáková L; Habalová V; Sivoňová M; Nagy V; Šalagovič J; Židzik J
Mol Biol Rep; 2011 Feb; 38(2):1287-93. PubMed ID: 20568013
[TBL] [Abstract][Full Text] [Related]
16. N-acetyl transferase 2/environmental factors and their association as a modulating risk factor for sporadic colon and rectal cancer.
Procopciuc LM; Osian G; Iancu M
J Clin Lab Anal; 2017 Sep; 31(5):. PubMed ID: 27883249
[TBL] [Abstract][Full Text] [Related]
17. The role of N-acetylation polymorphisms in smoking-associated bladder cancer: evidence of a gene-gene-exposure three-way interaction.
Taylor JA; Umbach DM; Stephens E; Castranio T; Paulson D; Robertson C; Mohler JL; Bell DA
Cancer Res; 1998 Aug; 58(16):3603-10. PubMed ID: 9721868
[TBL] [Abstract][Full Text] [Related]
18. Arylamine N-acetyltransferase 1 (NAT1) and 2 (NAT2) polymorphisms in susceptibility to bladder cancer: the influence of smoking.
Okkels H; Sigsgaard T; Wolf H; Autrup H
Cancer Epidemiol Biomarkers Prev; 1997 Apr; 6(4):225-31. PubMed ID: 9107426
[TBL] [Abstract][Full Text] [Related]
19. [Polymorphism in the N-acetyltransferase 2 gene in patients with lung cancer. Short communication].
Zabost A; Roszkowska-Śliż B; Wiatr E; Radzikowska E; Rogala E; Zych J; Zwolska Z; Augustynowicz-Kopeć E; Roszkowski-Śliż K; Szczepulska-Wójcik E
Pneumonol Alergol Pol; 2012; 80(4):323-8. PubMed ID: 22714076
[TBL] [Abstract][Full Text] [Related]
20. An association of UDP-glucuronosyltransferase 2B7 C802T (His268Tyr) polymorphism with bladder cancer in benzidine-exposed workers in China.
Lin GF; Guo WC; Chen JG; Qin YQ; Golka K; Xiang CQ; Ma QW; Lu DR; Shen JH
Toxicol Sci; 2005 May; 85(1):502-6. PubMed ID: 15615884
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
